NFE2L2 and neuroblastoma: Overexpression of Nrf2 may increase resistance to chemotherapies such as cisplatin, doxorubicin, etoposide (lung carcinoma, mammary adenocarcinoma, neuroblastoma cell lines), highlighting its likely involvement in chemoresistance phenomena [25].